Ligand Pharmaceuticals (LGND) Total Debt Growth (1y) (2012 - 2019)
Ligand Pharmaceuticals (LGND) Total Debt Growth (1y) (2012 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -87.12% |
| Mar 31, 2019 | -88.24% |
| Dec 31, 2018 | -88.23% |
| Sep 30, 2018 | -3.80% |
| Jun 30, 2018 | -3.78% |
| Mar 31, 2018 | 5.47% |
| Dec 31, 2017 | 5.46% |
| Jun 30, 2017 | 5.43% |
| Dec 31, 2016 | -47.73% |
| Dec 31, 2015 | 107.93% |
| Mar 31, 2013 | -80.33% |
| Dec 31, 2012 | -55.61% |
| Sep 30, 2012 | -40.81% |